Fundz

Racura Oncology raises $34.3 million in a funding round to advance its clinical programs in cancer treatment.

PRIVATEJun 17, 2026

Amount Raised

$34.3 Million

Round Type

Funding Round

SydneyBiotechnologyHealth CareMedicalTherapeutics

Description

Racura Oncology has secured $34.3 million following a series of fundraising initiatives supported by new and existing shareholders. This funding will enable the company to fully finance its RC220 clinical programs. These programs focus on Acute Myeloid Leukaemia, EGFRm non-small cell lung cancer, and anthracycline cardioprotection. The additional funds provide a strong cash balance for the company's ongoing research efforts.

Quick answer

Racura Oncology raised $34.3 Million in a Funding Round round, dated June 17, 2026. Racura Oncology is based in Sydney, New South Wales, Australia.

How much did Racura Oncology raise?
Racura Oncology raised $34.3 Million in a Funding Round round on June 17, 2026.
What does Racura Oncology do?
Racura Oncology is a biopharmaceutical company focused on developing innovative treatments for cancer.
Where is Racura Oncology based and how big is it?
Racura Oncology is based in Sydney, New South Wales, Australia. Fundz records about 17 employees.
Who are the decision-makers at Racura Oncology?
Fundz holds 1 contact at Racura Oncology, including the Non Executive Director. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Medical and Therapeutics around the same time

Companies in the same sectors as Racura Oncology that raised within 45 days of this round, from Fundz verified event records.

  • Adjuvia Therapeutics raised $8M (Seed) on July 29, 2026.
  • Scancell Holdings PLC raised $39M (Post-IPO Equity) on July 23, 2026.
  • Georgiamune raised $93M on July 16, 2026.
  • Imagion Biosystems raised $2.8M (Post-IPO Equity) on June 25, 2026.
  • Gate2Brain raised $8.1M on June 16, 2026.
  • Kordata Dynamics raised an undisclosed amount (Pre-Seed) on May 21, 2026.

Who to call at Racura Oncology, and when

A new round usually means Racura Oncology is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Racura Oncology raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Racura Oncology, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Racura Oncology. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Racura Oncology

Location

Sydney, New South Wales, Australia

About

Racura Oncology is a biopharmaceutical company focused on developing innovative treatments for cancer. The company is advancing several clinical programs, notably in Acute Myeloid Leukaemia and non-small cell lung cancer. Racura is also exploring treatments aimed at cardioprotection in solid tumor patients. With significant fundraising success, Racura is positioned to enhance its clinical trials.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Racura Oncology raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Verified contactsSerge S., Non Executive Director hiddenSee plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for Racura Oncology's next move

See what Strategic adds

Racura Oncology raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.